Completed PHASE3 INTERVENTIONAL 4-arm NCT00838903

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus

Sponsor: GlaxoSmithKline

Conditions Diabetes Mellitus, Type 2

Interventions albiglutide glimepiride metformin placebo albiglutide placebo glimepiride placebo sitagliptin sitagliptin

Updated 7 times since 2017 Last updated: Nov 18, 2016 Started: Feb 28, 2009 Primary completion: Jan 31, 2012 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diabetes Mellitus, Type 2, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Alabaster, Albania , Albuquerque, United States , Arkansas City, United States , Arkhangelsk, Russia , Arlington, United States , Arvada, United States , Asheboro, United States , Asheville, United States , Ashland, United States and 306 more locations